About this product

This Swine Mycoplasma Hyopneumoniae Vaccine, Live (Strain 168) is a critical biological product designed for the prevention of enzootic pneumonia in swine, a significant respiratory disease impacting pig health and productivity. The vaccine's primary function is to stimulate a robust immune response against Mycoplasma hyopneumoniae, thereby reducing the incidence and severity of clinical signs associated with the infection. Utilizing a live attenuated strain, Strain 168, this vaccine offers a highly effective means of prophylaxis. While specific technical specifications and performance characteristics are best discussed directly with the manufacturer, live vaccines of this nature are typically formulated for optimal antigenicity and stability. The vaccine is manufactured under stringent quality control measures to ensure purity, potency, and safety. It is available in various vial sizes to accommodate different herd management needs, with customisation options for bulk orders potentially available upon direct inquiry. This product is ideally suited for swine producers, veterinarians, and animal health distributors seeking to implement comprehensive disease prevention programs. Its application is widespread across the global swine industry, from large-scale commercial farms to smaller breeding operations. For international trade buyers, this vaccine represents a reliable and essential component for maintaining herd health, improving economic returns, and ensuring compliance with animal welfare standards, making it a valuable addition to any livestock health portfolio.